SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001354488-12-000844
Filing Date
2012-02-23
Accepted
2012-02-23 14:58:22
Documents
13
Period of Report
2011-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT tdlp_10k.htm 10-K 1843567
2 CONSENT tdlp_ex231.htm EX-23.1 2942
3 CERTIFICATION tdlp_ex311.htm EX-31.1 19318
4 CERTIFICATION tdlp_ex312.htm EX-31.2 19361
5 CERTIFICATION tdlp_ex321.htm EX-32.1 8639
6 CERTIFICATION tdlp_ex322.htm EX-32.2 8960
7 img001.jpg GRAPHIC 20605
  Complete submission text file 0001354488-12-000844.txt   3742729

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT tdlp-20111231.xml EX-101.INS 322915
9 XBRL TAXONOMY EXTENSION SCHEMA tdlp-20111231.xsd EX-101.SCH 14876
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE tdlp-20111231_cal.xml EX-101.CAL 32958
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE tdlp-20111231_def.xml EX-101.DEF 24443
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE tdlp-20111231_lab.xml EX-101.LAB 111508
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tdlp-20111231_pre.xml EX-101.PRE 82732
Mailing Address 4225 EXECUTIVE SQUARE SUITE 485 LA JOLLA CA 92037
Business Address 4225 EXECUTIVE SQUARE SUITE 485 LA JOLLA CA 92037 (858) 457-5300
TRANSDEL PHARMACEUTICALS INC (Filer) CIK: 0001360214 (see all company filings)

IRS No.: 450567010 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-52998 | Film No.: 12633418
SIC: 2834 Pharmaceutical Preparations